Cargando…
An open-label, non-comparative, non-interventional, multi-center, post-authorization safety study on the administration of rabeprazole to adults with gastro-esophageal reflux disease
BACKGROUND: Rabeprazole produces a profound and long-lasting inhibition of gastric acid secretion. The aim of the study was to monitor the safety and efficacy of rabeprazole administered to patients with erosive or symptomatic non-erosive reflux disease, in real-life healthcare settings. METHODS: Ma...
Autores principales: | Zouboulis-Vafiadis, Irini, Paraskevas, Emmanuel, Tzourmakliotis, Dimitrios, Hatzikyriakou, Maria, Mestoussi, Angeliki, Vasdekis, Vassilios, Katsilabros, Nikolaos, Arhimandritis, Athanasios, Papadokostopoulou, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982628/ https://www.ncbi.nlm.nih.gov/pubmed/24732963 |
Ejemplares similares
-
Protocol of a randomized, double-blind, placebo-controlled study of the effect of probiotics on the gut microbiome of patients with gastro-oesophageal reflux disease treated with rabeprazole
por: Liu, Wenjun, et al.
Publicado: (2022) -
Gastro-Esophageal Reflux in Children
por: Rybak, Anna, et al.
Publicado: (2017) -
The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease
por: Chen, Ying, et al.
Publicado: (2013) -
Significance of Non-erosive Minimal Esophageal Lesions in Gastro-esophageal Reflux Disorder
por: Hong, Sung-Pyo, et al.
Publicado: (2004) -
Non-acid gastro-oesophageal reflux is associated with squamous cell carcinoma of the oesophagus
por: Kgomo, Mpho, et al.
Publicado: (2017)